This report shares the key insights from a MAPS special session on Field Medical engagement and provides further context from Medical Affairs colleagues who have first-hand knowledge of the ever-changing Field Medical role.
The objective of this podcast is to discuss how the 21st Century Cures Act has led to new initiatives at FDA involving Real World Evidence.
MAPS speaks with co-leads of the Insights Focus Area Working Group (FAWG) about the current state and future directions for Insights in Medical Affairs.
This 8th episode in our Field Medical podcast series explores the evolving roles of MSLs in the context of clinical trials.
Events of the last 12 months have driven the pharmaceutical industry to more comprehensively examine how it can address ethnic and racial disparities in health outcomes and clinical research access. It is well accepted that diversity of clinical trial participants is essential to ensure that the trial population is truly representative of the patients who will use the therapy, yet disparities in clinical trial participation remain. A multi-faceted approach is required to understand the critical barriers to clinical research access for patients from diverse backgrounds.
During this thought-provoking webinar, our panel of internationally renowned Patient Advisors and Diversity Experts will share their perspectives on diverse representation in clinical trials and key barriers to research access, and explore solutions to address these critical issues.
This program will:
• Define health economics and outcomes research (HEOR) and its relationship to Medical Affairs
• Understand HEOR professional competencies included in the ISPOR Competency Framework, and which are most relevant to Medical Affairs professionals
• Discuss potential applications of the competencies by different stakeholders (employers, new professionals, students, academia)
• Identify ways for Medical Affairs professionals to further their HEOR knowledge and skills
In this edition of Perspectives, MAPS Americas Region President, Dr John Pracyk speaks with J&J leaders about the keys to success in Medical Affairs.
This paper explores how moving to a holistic, multi-channel approach to insights will create value for the organization, patients and the medical community.
This podcast offers insights surrounding common challenges Medical Affairs organizations face in offering best-in-class digital capabilities.
This session will provide a learning opportunity for our audience by describing:
• An evolved Medical Communications function, by articulating the critical capabilities that make it a driver of strategic scientific communications aligned with overall medical imperatives
• A “Supernova” MA Therapeutic Area (strategy) and Medical Communications Team: An empowered Medical Communications department is a strategic partner to Therapeutic Area teams and exponentially increasing the value of MA deliverables
• The rationale and approach for developing a strategic Medical Communications Strategy and its components